Gd-DTPA contrast enhancement and tissue differentiation in MR imaging of experimental breast carcinoma.
Gadolinium-DTPA (Gd-DTPA) enhancement of magnetic resonance (MR) imaging was tested for diagnostic utility in evaluating carcinoma. Human breast carcinoma implanted in ten nude mice was studied before and after injection of Gd-DTPA at two different doses (0.2 and 0.5 mmol/kg body weight). Before injection, all tumors appeared homogeneous in intensity on spin-echo images; after injection, it was possible to distinguish areas of strong enhancement from areas of weak enhancement. Histologic correlations showed that the strongly enhanced areas corresponded to richly vascularized connective tissue and apparently viable tumoral tissues, while the weakly enhanced areas corresponded to nonvascularized necrotic tissue. The results indicate that intravenously administered paramagnetic agents such as Gd-DTPA may improve the specificity and diagnostic accuracy of MR imaging by permitting better differentiation of tumor elements.
Revel
D
D
Brasch
R C
RC
Paajanen
H
H
Rosenau
W
W
Grodd
W
W
Engelstad
B
B
Fox
P
P
Winkelhake
J
J
D000328:Adult; D000818:Animals; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000473:pathology; D002460:Cell Line; D003287:Contrast Media; D005260:Female; D005682:Gadolinium / Q000494:pharmacology; D006801:Humans; D009682:Magnetic Resonance Spectroscopy / Q000379:methods; D051379:Mice; D008819:Mice, Nude; D004369:Pentetic Acid; D013194:Staining and Labeling
D003287:Contrast Media; D004369:Pentetic Acid; D005682:Gadolinium